Le Lézard
Classified in: Health
Subject: SLS

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2024


GOTHENBURG, Sweden, June 5, 2024 /PRNewswire/ -- Zinzino group revenue increased with a total of 24%, compared with the previous year.

The revenue in May for Zinzino's sales markets increased by 23 % and amounted to SEK 172.3 (139.9) million. Faun Pharma's external sales increased by 31 % and amounted to SEK 9.2 (7.0) million. Overall, the Group increased revenues by 24 % to SEK 181.5 (146.9) million compared with the previous year.

Accumulated revenue for January ? May 2024 increased by 21 % to SEK 802.2 (661.8) million.

Revenues were distributed as follows:

Regions,MSEK

24-May

23-May

Change

YTD 2024

YTD 2023

Change

The Nordics

25.3

26,0

-3 %

118.6

121.1

-2 %

Central Europe

49.2

34.2

44 %

214.1

154.4

39 %

East Europe

34.7

34.0

2 %

159.5

157.1

2 %

South & West Europe

33.2

25.0

33 %

130.2

89.6

45 %

The Baltics

8.8

7.6

16 %

40.8

35.7

14 %

North America

15.1

7,0

116 %

65.8

32.4

103 %

Asia-Pacific

4.7

4.7

0 %

22.5

25.5

-12 %

Africa

1.3

1.4

-7 %

5.7

6.2

-8 %

Zinzino

172.3

139.9

23 %

757.2

622.0

22 %

Faun Pharma

9.2

7.0

31 %

45.0

39.8

13 %

Zinzino Group

181.5

146.9

24 %

802.2

661.8

21 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge: [email protected]

Certified Adviser: Carnegie Investment Bank AB (publ)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-may-2024,c3995447

The following files are available for download:

https://mb.cision.com/Public/10976/3995447/92ebe4d7be0abd3b.pdf

2405 Pressrelease Salesreport EN

 


These press releases may also interest you

at 22:39
In a groundbreaking medical feat, LiverIndia's Dr Karthik Mathivanan, a renowned Liver Transplant surgeon in Chennai with over 15 years of experience in multi-organ transplant surgery, has successfully utilised the emerging field of transplant...

at 20:00
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 225Ac-FL-020, the company's lead radiopharmaceutical,...

at 19:30
Vitality Products Inc. (the "Company" or "Vitality"), a manufacturer, marketer and distributor of premium vitamins and supplements, is pleased to report its financial results for the first quarter ended April 30, 2024 and provide a business update....

at 18:05
Teva Pharmaceutical Industries Ltd. announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live...

at 18:05
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announced that it has closed a non-brokered private placement,...

at 18:00
Global technology2use company CHG-MERIDIAN continues its strong growth path in Australia and New Zealand (ANZ) with the acquisition of Maia Financial Pty Limited's (Maia Financial) asset portfolio on June...



News published on and distributed by: